Treatments for Breast Cancer

Nerlynx (Neratinib)

Overview
Nerlynx is a prescription drug approved by the Food and Drug Administration (FDA) as adjuvant (post-surgery) treatment for adults with early-stage breast cancer in which HER2 is overexpressed or ampli... read more

Neulasta (Pegfilgrastim)

Overview

Neulasta is a prescription drug approved by the Food and Drug Administration (FDA) to lower the risk of developing infections after receiving chemotherapy or some types of radiation. Neulasta is als... read more

Neupogen (Filgrastim)

Overview
Neupogen is a prescription drug approved by the Food and Drug Administration (FDA) to help prevent febrile neutropenia (a lack of white blood cells, plus fever). If your white blood cell count is low ... read more

Ogivri (Trastuzumab-dkst)

Overview
Ogivri is a prescription drug approved by the Food and Drug Administration (FDA) to treat breast cancer in cases where tumors overexpress the HER2 protein. Ogivri is also known by its drug name, Trast... read more

Perjeta (Pertuzumab)

Overview
Perjeta is a prescription drug approved by the Food and Drug Administration (FDA) to treat metastatic breast cancer in cases where tumors overexpress the HER2 protein and chemotherapy or anti-HER2 the... read more

Pertuzumab

Overview
Pertuzumab is a prescription drug approved by the Food and Drug Administration (FDA) to treat metastatic breast cancer in cases where tumors overexpress the HER2 protein and chemotherapy or anti-HER2 ... read more

Radiation Therapy

Overview
Radiation therapy helps prevent the return or spread of cancer. It is most frequently used after surgery, especially lumpectomy. If you hav... read more

Reconstructive Surgery

Overview
Many women choose reconstructive surgery after a mastectomy or bilateral... read more

Sentinel node biopsy

Overview
Sentinel node biopsy is the surgical removal of one or more lymph nodes for testing. It is a diagnostic procedure performed in order to determine whether breast cancer has developed the ability to spr... read more

Tamoxifen

Overview
Tamoxifen is a prescription drug first approved by the Food and Drug Administration (FDA) in 1977 to treat breast cancer. Tamoxifen was later also approved to prevent breast cancer. Tamoxifen is commo... read more

Trastuzumab

Overview
Trastuzumab is a prescription drug approved by the Food and Drug Administration (FDA) to treat metastatic breast cancer in cases where tumors overexpress the HER2 protein and one or more chemotherapy ... read more

Tykerb (Lapatinib)

Overview
Tykerb is a prescription drug approved by the Food and Drug Administration (FDA) in 2007 to treat metastatic breast cancer in combination with Capecitabine in cases where tumors overexpress the HER2 p... read more

Verzenio (Abemaciclib)

Overview
Verzenio is a prescription drug approved by the Food and Drug Administration (FDA) to treat advanced or metastatic breast cancer. Verzenio may be prescribed in combination with Faslodex (Fulvestrant),... read more

Xeloda (Capecitabine)

Overview
Xeloda is a prescription drug approved by the Food and Drug Administration (FDA) to treat metastatic breast cancer. Xeloda may be prescribed either as monotherapy (on its own) in cases resistant to pa... read more

Zarxio (Filgrastim-sndz)

Overview
Zarxio is a prescription drug approved by the Food and Drug Administration (FDA) to treat febrile neutropenia (a lack of white blood cells, plus fever). If you have neutropenia caused by chemotherapy ... read more